Literature DB >> 8163572

Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-beta.

R T Ballock1, A Heydemann, L M Wakefield, K C Flanders, A B Roberts, M B Sporn.   

Abstract

Retinoic acid has been identified as a key morphogen governing pattern formation in the developing cartilaginous skeleton. Retinoids have also been implicated in the premature closure of the cartilage growth plate following vitamin A intoxication or administration of retinoids for dermatologic conditions. Previous studies of the mechanism of action of retinoids in non-chondrogenic cells have concluded that retinoic acid is a negative regulator of AP-1 responsive metalloprotease genes. We show that inhibition of expression of the cartilage phenotype by retinoic acid in epiphyseal chondrocytes is associated with positive regulation of AP-1 responsive metalloprotease genes, as well as induction of gene expression for the two components of the transcription factor AP-1, c-fos and c-jun. Despite the similar effects of TGF-beta 1 on expression of cartilage matrix proteins and metalloproteases in this culture system, no appreciable changes in the expression of TGF-beta isoforms were evident in response to retinoic acid treatment. The present investigation demonstrates that regulation of AP-1 responsive genes by retinoic acid can be either positive or negative, depending on the target cell type, and illuminates new mechanisms by which retinoic acid and other retinoids may exert control during development and growth of the limb.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163572     DOI: 10.1002/jcp.1041590217

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.

Authors:  A H Ree; G M Maelandsmo; O Fodstad
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

Review 2.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.

Authors:  D J Schroen; C E Brinckerhoff
Journal:  Gene Expr       Date:  1996

3.  Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system.

Authors:  Karl W Kavalkovich; Raymond E Boynton; J Mary Murphy; Frank Barry
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-09       Impact factor: 2.416

4.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease.

Authors:  Ian D Welch; Matthew F Cowan; Frank Beier; Tully M Underhill
Journal:  Arthritis Res Ther       Date:  2009-01-28       Impact factor: 5.156

5.  Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover.

Authors:  Rika Yasuhara; Takahito Yuasa; Julie A Williams; Stephen W Byers; Salim Shah; Maurizio Pacifici; Masahiro Iwamoto; Motomi Enomoto-Iwamoto
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

6.  A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation.

Authors:  M J Jiménez; M Balbín; J Alvarez; T Komori; P Bianco; K Holmbeck; H Birkedal-Hansen; J M López; C López-Otín
Journal:  J Cell Biol       Date:  2001-12-17       Impact factor: 10.539

7.  Theranostic immunoliposomes for osteoarthritis.

Authors:  Hongsik Cho; John M Stuart; Richard Magid; Delia C Danila; Tamra Hunsaker; Eugene Pinkhassik; Karen A Hasty
Journal:  Nanomedicine       Date:  2013-10-02       Impact factor: 5.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.